Treating Dyslipidemias: Is Inflammation the Missing Link?

ISSN: 1875-6638 (Online)
ISSN: 1573-4064 (Print)

Volume 11, 8 Issues, 2015

Download PDF Flyer

Medicinal Chemistry

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Honorary Life Fellow
Kings College
University of Cambridge

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 1.363
5 - Year: 1.388

Treating Dyslipidemias: Is Inflammation the Missing Link?

Medicinal Chemistry, 10(7): 643-652.

Author(s): Nikolaos Papoutsidakis, Spyridon Deftereos, Georgios Giannopoulos, Vasiliki Panagopoulou, Antonis S. Manolis and Georgios Bouras.

Affiliation: Department of Cardiology, Athens General Hospital “G. Gennimatas”, Mesogeion 154, 11527, Athens, Greece.


Low-grade chronic inflammation is now being held as an important process in the development of atherosclerosis, with new links between dyslipidemia and inflammation being constantly found. While most studies aim to discover inflammatory pathways leading from dyslipidemia to atherogenesis, there is evidence that inflammation can also act in reverse, altering lipid metabolism in unfavorable ways, possibly creating a vicious cycle of inflammationdyslipidemia- inflammation. This is highly relevant for the search of novel therapeutic targets. In this review, after a brief account of the inflammatory mechanisms leading from dyslipidemia to atherogenesis, we focus on what is currently known about the ways inflammation can impair lipid metabolism and whether anti-inflammatory therapies could have a role in dyslipidemia management.


Atherosclerosis, CAD, cholesterol, dyslipidemia, inflammation, lipids.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 10
Issue Number: 7
First Page: 643
Last Page: 652
Page Count: 10
DOI: 10.2174/1573406410666140318101936

Related Journals

Webmaster Contact: Copyright © 2015 Bentham Science